Fulltext search has been disabled for Key Event Relationships (KERs) at this time. If you need this feature, send an email to aopwiki@googlegroups.com

Queries Key Event Relationship (KER) titles
Filter by Upstream Key Event title
Filter by Downstream Key Event title
Filter by AOP title

Showing 2651 to 2675 of 2767 KERs

Clear Table Filters
ID Upstream Event Downstream Event Creation Date Last Updated AOPs
3220 2226: Binding PPAR isoforms 2227: Disrupted PPAR isoform nuclear signaling May 14, 2024 May 23, 2024
1968 1671: Substance - LS interaction 1672: Inhibition of LS function. Jul 3, 2019 Jul 3, 2019 None
1702 1495: Interaction with the lung cell membrane 1496: Increased proinflammatory mediators Jan 5, 2018 Aug 29, 2023
2662 1495: Interaction with the lung cell membrane 1115: Increased, Reactive oxygen species May 25, 2022 May 25, 2022
2663 1495: Interaction with the lung cell membrane 1669: Increased, DNA damage and mutation May 25, 2022 May 25, 2022
2958 1495: Interaction with the lung cell membrane 1438: Increased transcription of genes encoding acute phase proteins Jul 4, 2023 Dec 19, 2023
2959 1495: Interaction with the lung cell membrane 1439: Systemic acute phase response Jul 4, 2023 Dec 19, 2023
2960 1495: Interaction with the lung cell membrane 1443: Atherosclerosis Jul 4, 2023 Dec 18, 2023
2866 2118: SDH, inhibited 2120: Superoxide generation, increased Apr 3, 2023 May 4, 2023
2895 2118: SDH, inhibited 1969: Increase, Oxidative Stress Apr 24, 2023 Apr 24, 2023 None
2896 2120: Superoxide generation, increased 1969: Increase, Oxidative Stress Apr 24, 2023 Jun 1, 2023
1817 1565: Suppressed AP-1 1567: Suppressed DC activation Dec 25, 2018 Dec 25, 2018 None
1819 1567: Suppressed DC activation 1568: Impaired antigen presentation Dec 25, 2018 Dec 25, 2018 None
1826 1573: Suppressed MyD88 986: Impairment of TDAR Jan 6, 2019 Jan 6, 2019 None
1870 1573: Suppressed MyD88 202: Inhibition, Nuclear factor kappa B (NF-kB) Mar 12, 2019 Mar 12, 2019 None
1818 1566: Suppressed NF-kB 1567: Suppressed DC activation Dec 25, 2018 Dec 25, 2018 None
2001 1702: Suppression of T cell activation 202: Inhibition, Nuclear factor kappa B (NF-kB) Nov 17, 2019 Nov 17, 2019 None
2004 1702: Suppression of T cell activation 986: Impairment of TDAR Nov 17, 2019 Mar 2, 2023 None
2927 1702: Suppression of T cell activation 1700: Impaired IL-1R1 signaling May 24, 2023 May 24, 2023 None
2928 1702: Suppression of T cell activation 984: Impairment, T-cell dependent antibody response May 24, 2023 May 25, 2023
2027 1718: Suppression of IL-4 production 1719: Impairment, TDAR Jan 5, 2020 Apr 4, 2021
2026 1717: Suppression of STAT5 binding to cytokine gene promoters 1718: Suppression of IL-4 production Jan 5, 2020 Mar 30, 2021
476 456: Suppression, Constitutive androstane receptor, NR1l3 167: Activation, LXR Nov 29, 2016 Dec 3, 2016
477 456: Suppression, Constitutive androstane receptor, NR1l3 228: demethylation, PPARg promoter Nov 29, 2016 Dec 3, 2016
1086 1046: Suppression, Estrogen receptor (ER) activity 1056: Decrease, E2 blood concentrations at hypothalamus Nov 29, 2016 Dec 3, 2016